Consumer Responses to Price Disclosure in Direct-to-Consumer Pharmaceutical Advertising

Jace B Garrett; William B Tayler; Ge Bai; Mariana P Socal; Antonio J Trujillo; Gerard F Anderson

doi:10.1001/jamainternmed.2018.5976

Consumer Responses to Price Disclosure in Direct-to-Consumer Pharmaceutical Advertising

JAMA Intern Med. 2019 Mar 1;179(3):435-437. doi: 10.1001/jamainternmed.2018.5976.

Authors

Jace B Garrett¹, William B Tayler², Ge Bai³, Mariana P Socal⁴, Antonio J Trujillo⁴, Gerard F Anderson⁴

Affiliations

¹ School of Accountancy, College of Business, Clemson University, Clemson, South Carolina.
² School of Accountancy, Marriott School of Business, Brigham Young University, Provo, Utah.
³ Johns Hopkins Carey Business School, Baltimore, Maryland.
⁴ Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Abstract

This survey-based behavioral experiment was conducted to understand how consumers are likely to respond to including the drug price in any direct-to-consumer pharmaceutical advertising.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Direct-to-Consumer Advertising*
Disclosure*
Humans
Prescription Fees*
Public Opinion*
United States